Adefovir dipivoxil, 10 mg p.o. daily, is safe and effective in the treatment of chronic hepatitis due to HBV, regardless of the presence or absence of HBeAg, and it did not select resistant mutants after 48 weeks of administration.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content